Dosage of GLP-1 analogues
US$ 21.68
glp-1 agonists for type 2 diabetes The activity of and GIP and Obesity Comparing Ozempic, Wegovy and Other
Description
2015Lixisenatide in patients with type 2 diabetes and acute coronary syndrome
These factors have fostered the development and widespread adoption of innovative treatments like glucagon-like peptide 1 analogs
doi: 10.1016/S2213-8587(15)00482-9
Most prescribing guidelines recommend 8 to 12 weeks of treatment, followed by a break
The search strategy employed the following terms: (Incretin Mimetics OR GLP-1 receptor agonists) AND (pancreatic cancer OR pancreatic adenocarcinoma OR pancreatic effects)
